[56]
U.S. Patent 3,917,609 disclosed tricylic fluorquinolone, an antibacterial compound, and indicated that one of the optically active isomers was much more active as an antibacterial agent. U.S. Patent 3,976,651 disclosed another tricylic fluorquinolone that had found one isomer to have more antimicrobial activity than the other. According to Dr. Caldwell, these are racemic compounds similar in structure to ofloxacin.